Kardium is a medical device company, working on a revolutionary treatment for a heart rhythm disorder called atrial fibrillation, which affects over 40 million people worldwide. Kardium has assembled a world-class team of engineers, researchers and developers to develop the Globe® mapping and ablation system. The Globe system is a sophisticated electro-mechanical catheter, driven by advanced software, developed and manufactured by the Kardium team in Vancouver.
Today, atrial fibrillation is primarily treated by using a catheter with a single electrode to create lesions in a patient’s atrium. The Globe catheter has 122 electrodes that are deployed in an expanding array, into the patient’s atrium. This array of electrodes allows the physician to easily create maps of the atrial anatomy and electrical activity of the atrium. The physician can then use the same electrodes to easily create all the necessary lesions, treating the atrial fibrillation with a single device.
The Globe system is currently undergoing clinical studies in Europe and Kardium expects the Globe system will have a major impact on the diagnosis and treatment of atrial fibrillation in the future. Kardium was awarded “Medical Technology Company of the year” in 2015 by LifeSciences BC.
Kardium is ISO 13485 certified.
Date: Tuesday, October 24, 2017
Location: 155 – 8518 Glenlyon Parkway, Burnaby, BC, V5J 0B6
6:00 – 6:10pm Introduction – LifeSciences BC and ASQ
6:15 – 6:35pm Kardium company overview – 20 minutes
6:40 – 7:40pm Tour
7:40 – 8:00pm Networking & wrap up
For more information please contact:
Ryan Butt, Manager Events & Outreach
Phone: 604 669-9909 ext. 104 & Email: email@example.com